Division of Aging Biology Notices of Funding Opportunities
DAB is currently seeking applications in response to notices of funding opportunities (NOFOs) in the biology of aging and in geroscience. Please see below for active NOFOs developed by DAB or joined by DAB. DAB also seeks applications related to Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) in some specific areas.
The full list of NIA-wide active notices of funding opportunities and NIA-wide AD/ADRD funding opportunities can be found online. Read NIA's research and funding frequently asked questions.
The table below contains notices of funding opportunities that are currently being funded in full or in part by the Division of Aging Biology (DAB).
NOFO Number | Title | Released | Expires | DAB Contact |
---|---|---|---|---|
PAR-22-127 | Focused Technology Research and Development (R01 Clinical Trial Not Allowed) | 21-Mar-22 | 8-May-25 | Leonid Tsap, Ph.D |
PAR-22-126 | Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) | 21-Mar-22 | 8-May-25 | Leonid Tsap, Ph.D |
RFA-AG-23-016 | Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) | 11-Apr-22 | 19-Oct-24 | NIA Training Office |
Notice of Special Interest (NOSI): Role of Age-Associated Metabolic Changes in Alzheimer's Disease | 7-Jan-22 | 13-Nov-24 | Yih-Woei Fridell, Ph.D | |
Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) | 18-Nov-22 | 8-Jan-26 | Leonid Tsap, Ph.D | |
NOT-AG-23-004 | Notice of Special Interest (NOSI): Small Business Digital Technologies for Early Detection, Characterization and Monitoring of Senescence-Related Changes | 7-Feb-23 | 6-Jan-26 | Leonid Tsap, PhD |
NOT-EB-23-002 | Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications | 16-May-23 | 17-May-26 | Ronald Kohanski, Ph.D |
NOT-CA-23-092 | Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research | 16-Oct-23 | 31-Jul-27 | Max Guo, Ph.D |